On the day after president Donald Trump’s announcement that the Food and Drug Administration (FDA) had granted his request for an Emergency Application (EUA) to treat...

German drug discovery and development company Evotec has struck four separate partnership agreements during August.

UK biopharma Celleron Therapeutics has signed a licensing deal with Roche, gaining exclusive worldwide rights to the Swiss pharma’s monoclonal antibody emactuzumab, which...

Sanofi has agreed to buy US-based Principia Biopharma for $3.68 billion, strengthening its pipeline of treatments for autoimmune disorders. The deal gives the French...

As the US death toll from Covid-19 creeps past the 170,000 mark, with a proven vaccine still months away, US president Donald Trump has begun promoting yet another...

Maire Tecnimont’s green chemistry division NextChem has formed a partnership with Brazilian industrial biotech GranBio to co-license the latter’s patented technology to...

German biotech CureVac has more than tripled its market value to over $5 billion in an initial public offering launched on the US Nasdaq Global Market. Altogether 13.33...

Animal health biopharma Invetx has launched an antibody-based platform for the discovery and development of novel medicines for veterinarians and pet owners.

Bayer is to acquire UK biotech Kandy Therapeutics in a move that will expand its drug development pipeline in women’s healthcare.